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GENERAL INTRODUCTION 
Treponema hyodysenteriae, a gram n egative spirochete. is the 
etiologic agent of swine dysentery (64) . Swine dysentery is a muco-
h emorrhagic diarrhea of young feeder pigs causing morbidity and 
mortality (63) . This disease h as been estimated to cost the pork 
producer 100 million dollars annually (125). It was reported that the 
lipopolysaccharide (LPS). a component of the outer membrane of gram 
negative bacteria (121). of T. hyodysenteriae could be contributing to 
the pathogenesis of this disease (129). This molecule has been shown 
to cause a wide range of effects on the mammaliam system that 
resemble the pathophysiolgy of a gram negative septicemia (i.e., fever 
and inflammation) (120, 121, 141) . 
This research was performed to define the role of LPS and 
endotoxin of T. hyodysenteriae in the pathogenesis of swine dysentery. 
The first part of the study was to define the chemical content of the 
treponemal preparations (LPS and endotoxin) and to examine the 
classical biologic responses elicited. The second part of this study was 
to examine the biologic effects of treponemal LPS and endotoxin 
preparations on lymphoreticular cells. 
Explanation of thesis format The alternative format was used in 
preparing this thesis. Two manuscripts were written for Infection and 
Immunity. The manuscripts are titled "Classic Biological Responses 
Induced by Lipopolysaccharide and Endotoxin of Treponema 
hyodysenteriae" and "Ability of Treponema Lipopolysaccharide and 
2 
Endotoxin to Induce Cytokine Release from Lymphoreticular Cells". 
A general review of the literature is followed by the first 
manuscript with an overall summary following the second manuscript. 
Literature cited are referenced at the end of each manuscript. The 
literature cited in the general literature review and overall summary are 
cited in a literature cited section after the second manuscript. 
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LITERATURE REVIEW 
Lipopolysaccharide (LPS) from the members of the 
Enterobacteriaceae, such as Escherichia coli and Salmonella minnesota, 
has been extensively studied, both chemically and biologically (29, 98, 
120, 119) . LPS is a heat resistant, amphipathic molecule ranging in 
molecular weight from 20,000 to 1,000,000 daltons (98). Structurally, 
classical LPS has three regions (92): 1) a polysaccharide region 
designated as the 0-specific side chain (183). This hydrophilic portion 
is associated with the serologic classification of the organisms. 
Polyclonal rabbit serum, immunized with a variety of antigenic 
preparations, is used to differentiate strains due to similiar antigenic 
epitopes within the 0-speciflc side chain (0-antigen) (58, 91, 90, 92). 
2) The core region is made up of 2-keto-3-deox:yoctonate (KDO). L-
glycero-D-mannoheptose phosphate, and other repeating hexose sugars 
that can vary in character and number between genera (92). 3) The lipid 
A region is composed of a galactosamine disaccharide backbone with six 
or seven saturated fatty acid groups connected through phosphoester 
and/or amide bonds (92, 98). The biologic activity (i.e., toxicity, 
pyrogenicity, lethality, ... ) of LPS has been shown to be associated with 
the lipid A region (57, 55, 181). 
The LPS molecule can be prepared using different extraction 
procedures which give different characteristics to the product. The 
purest preparation of LPS is extracted by a hot phenol/water procedure 
of Westphal and Jann (180). This procedure removes virtually all of the 
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protein (precipitated in the phenol phase) leaving lipid and sugar 
moities as well as other water soluble materials in the aqueous phase. 
Rough or R mutant LPS is prepared with a phenol/chloroform/petroleum 
ether extraction as described by Galanos et al. (56). This procedure was 
developed to increase the recovery of LPS that had shorter carbohydrate 
side chains or proportionally more lipid thus changing the chemical 
characteristics. Other methods have been described that leave more 
protein in the preparation than do previous procedures. The 
trichloroacetic acid method (TCA) described by Boivin and Mesrobeanu 
(28), translated by Staub (159), and the butanol/water method of 
Morrison and Leive (118) leave large amounts of protein associated with 
the LPS. Historically, the TCA method was the first used to extract 
endotoxin; however, due to the acidic nature of the TCA procedure and 
the possible hydrolysis of the LPS, Morrison and Leive (118) devised the 
butanol/water method. The butanol/water method is more gentle than 
the phenol/water method, but it does not yield a purified LPS 
preparation. The LPS preparation extracted by the butanol/water 
procedure has the lipid-associated protein (LAP) attached to the LPS 
molecule. The LAP and LPS together are commonly referred to 
endotoxin. This constitutes a fourth region of the moiety as well as a 
molecular form which is more native to that found on the bacterium 
(121). 
The list of biologic effects associated with LPS or endotoxin includes 
the stimulation of B cell mitogenicity, immunogenicity, polycolonal 
antibody induction, adjuvanticity, stimulation of macrophage (119). 
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effects on the non-specific immune system {i.e., complement) {120). as 
well as pathophysiologic conditions such as fever and disseminated 
intravascular coagulopathy (141). Due to the large number of cell types 
{i.e., lymphocytes, macrophages, platelets, neutrophils, endothelial cells) 
{98) affected by LPS, this molecule would appear to play a major role in 
alerting the body to a gram negative bacterial infection (113) . 
Lipopolysaccharide is described as a T-independent antigen, 
inducing B cell proliferation {5, 110) . Andersson et al. (7) reported that 
a majority of B cells respond to LPS but only a small portion of that 
population were specific for 0 antigen. The following year, lipid A was 
isolated and shown to induce the B cell responses associated with LPS 
(6, 36, 135, 143). 
Conversely, LPS was shown to have no effect on T cell proliferation 
(8, 109, 135). However, there is evidence which indicated LPS can 
enhance the proliferation of T cells in the presence of T-dependent 
lectins {53, 132, 151). 
As an immunogen LPS has been shown to induce exceptionally high 
serum antibody responses when administered at a low dosage. This was 
shown by stimulating a primary immune response to the 0-specific side 
chain in the popliteal lymph node of rabbits following immunization with 
only 1000 molecules of purified endotoxin (83) . Rudbach reported that 
when mice were primed with a few hundred molecules of LPS, an 
enhanced secondary response to endotoxin immunization was seen 
(144). 
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Previous reports have established LPS as a T-independent antigen, 
however, there have been conflicting reports suggesting T cell and/or 
macrophage regulation upon endotoxin-induced B cell proliferation 
(111, 117, 119). Travniczek et al. (170) and Yoshinaga et al. (185) 
reported that macrophage could exert suppressive effects upon LPS-
induced B cell proliferation. Smith and Eaton demonstrated the 
presence of a subset of T cells that could inhibit LPS-induced B 
lymphocyte responses (157). Corbel and Melchers reported on a need 
for the combination of T cells and macrophages as accessory cells for for 
LPS-induced B cell stimulation (43). 
Lipopolysacchartde can also serve as an adjuvant for a humoral 
immune response (131). An adjuvant serves to potentiate the immune 
response to an antigen when both are administered simultaneously. The 
adjuvant response of LPS was first described by Johnson et al. (72) in 
1956 and then localized to the lipid A region of the molecule (36, 124, 
127). The adjuvant activity, as with B cell stimulation, was reported to 
be a T cell-independent response (109, 155). Conversely McGhee et al. 
(99) showed that the tr an sf er of T cells from LPS responsive mice to the 
LPS hyporesponsive C3H/HeJ mice resulted in a good adjuvant response. 
Thus, implicating T cells in some of the biologic responses induced by 
LPS. Additionally, LPS given with a toleragenic dose of antigen induced 
an immune response to the antigen (5, 38). 
The classes of antibodies to LPS produced by B lymphocytes are 
IgM, IgG, and IgA (119). The primary response seen was IgM and IgG 
(7, 76). The class of antibody was shown to vary according to the amount 
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and type of LPS given, as well as the immunization procedure (i.e., route) 
( 119). 
Suppression of the immune response has been associated with the 
administration of LPS and was found to be dependent upon the time 
difference between LPS administration and immunization with antigen 
(88, 136, 171). For example, LPS administered with antigen will act as 
an adjuvant, however, if LPS is given 24 hours prior to antigen, 
suppression of the immune response to that antigen will be seen (171). 
There are two possible hypotheses suggested for this suppression: 1.) a 
suppressor B cell population is generated (136); or 2.) a suppressive T 
cell response is stimulated by the LPS (170). McGhee et al. (100) 
indicated the involvement of T cells in the suppression of the mitogenic 
and immunogenic responses of B cells in conventional mice but not in 
germ free mice stimulated by LPS. 
An aspect that has not been addressed is the biologic activity of LAP 
and other outer membrane proteins, specifically porins, which are co-
extracted with LPS. Porins are trimeric complexes that serve as 
channels through the outer membrane of gram negative bacteria ( 1 7. 
139, 149). The porins are contaminants extracted with the endotoxin in 
the butanol/water procedure. They also stimulated B cell proliferation 
and polyclonal activity (20, 161, 175, 176). Skidmore et al. (155, 156) 
reported that there were differences between extraction procedures 
when using LPS to stimulate B cell proliferation of C3H/HeJ mice. 
Morrison et al. (115) and Sultzer and Goodman (162) separated a 
protein-rich portion from the phenol phase of endotox:in and tested the 
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fraction for stimulatory properties. They reported that the fraction 
induced B cell proliferation and acted as a polyclonal activator (115, 
162). These reports suggest that LAP stimulated B cells without T cell 
or macrophage involvement (61, 102, 162, 163). Hogan and Vogel 
reported that the LAP stimulated tumoricidal activity via interferon 
primed macrophages in C3H/HeJ mice in the absence of a response to 
LPS (68). Additionally, the presence of T cells stimulated by LAP may 
play a role in establishing an IgG class of antibody produced by B cells to 
LPS (65). Other cell types such as fibroblasts and mast cells have also 
been shown to respond to LAP (114, 115, 161) . 
Expression of Ia antigen has been shown to be essential for the 
induction of an immune response (14). Ia antigens are class II major 
histocompatibility antigens expressed on the surface of antigen 
presenting cells (APC) such as macrophage, T cells, and B cells (15, 173, 
172). Unless antigen is presented to B cells in conjunction with Ia, no 
immune response to the antigen developes (15, 173, 172). Endotoxins 
have been reported to activate Ia expression on B cells and macrophage 
through a T-independent mechanism (15, 16, 179, 186). This 
information indicates that the basis for the immunomodulation following 
treatment with LPS involves differential expression of cell surface 
markers without direct involvement from T cells. 
Activated macrophages are APCs which process antigens for delivery 
to lymphocytes, but they also function to stimulate lymphoblast formation 
via cytokine release (172). Macrophages stimulated with LPS synthesize 
and release cytokines such as interleukin 1 (ILl). colony stimulating 
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factor, interferon (IFN). glucocorticoid antagonizing factor, and tumor 
necrosis factor (TNF) or cachectin (98). There are many other products 
such as arachidonic acid metabolites and complement components that 
are also produced by macrophage (1). Many of these monokines have 
been shown to augment immune responses. 
Interleukin 1 (IL 1) is a hormone-like protein (15,000 daltons) that 
is primarily secreted by macrophage, but may also be produced by B 
lymphocytes, fibroblasts, endothelial cells, glioma cells, astrocytes, 
corneal epithilium, and large granular lymphocytes (49). This cytokine 
is made in response to a wide variety of stimulants including 
immunologic interactions (i.e., T cell-macrophage interactions) (102, 
104). immune complexes, C5a, microbial stimulants (i.e., lipid A of gram 
negative bacteria, gram positive bacterial exotoxins, muramyl dipeptide, 
yeast cell walls, virus hemagglutinins, and double-stranded RNA) (3, 49). 
and chemical stimulants (i.e. , silica crystals, urate crystals and phorbol 
myristate acetate) (49) . 
Interleukin 1 induces numerous biologic effects, one of which is 
important to the humoral response. This monokine serves as a stimulant 
for the T and B lymphocyte blastogenesis (108). When T cells are 
stimulated with IL 1, they produce IL 2 which causes T cell proliferation 
(49). This T cell population thus enhances the immune response to an 
antigen. Interleukin 1 has been reported as an endogenous pyrogen as 
well as a mediator of inflammation (49). Interleukin 1 stimulates 
macrophage, neutrophils, fibroblasts, synovium, endothelium, and 
hepatocytes to release prostaglandins, collagenases, and acute-phase 
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reactants which lead to an inflammatory state (19, 44). An example of 
this type of phenomenon can be demonstrated by the local Shwartzman 
reaction ( 13) . 
Tumor necrosis factor is a hormone secreted by macrophages 
activated by stimulants such as LPS (25, 93, 95, 96, 97). This molecule 
is a dimeric polypeptide with a monomeric molecular weight of 17,000 
daltons (22) . When secreted by cell lines or macrophages, TNF can 
account for 1-2% of the total protein produced in vitro (25) . 
As the name implies, TNF causes hemorrhagic necrosis of tumors 
(24). This was first exploited by injecting bacterial culture broth into 
patients with cancer (39, 40, 126). The hope was to induce tumor 
regression, however mixed results were observed (39, 40, 126). The 
mechanism of TNF activity on tumors is unknown. 
When TNF has been induced by exogenous stimulants, such as LPS, a 
general wasting or cachexic state of the host was observed. In 1985, 
Cerami et al. (34) reported that TNF given to endotoxin-resistant 
C3H/HeJ mice caused anorexia and weight loss. and if enough TNF was 
given, death occurred. The condition was described as metabolic 
acidosis with changes in plasma glucose levels, and inflammatory lesions 
in the lungs, gastrointestinal tract, kidneys. adrenal glands, and pancreas 
( 168). 
Tumor necrosis factor stimulation can induce biosynthesis and/or 
release of specific proteins. These proteins vary in nature from 
inflammatory agents such as prostaglandin E2, leukotrienes. platelet 
activating factor, and collagenase (24, 48), to class I major 
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histocompatibility antigens (42). and IL 1 (44) . Induction of IL 1 
resulted in fever, and, thus allowing TNF to be referred to as an 
endogenous pyrogen (45) . 
Numerous studies suggest that TNF is a major contributor to the 
effects caused by LPS (23, 25, 52, 168, 169). Beutler et al. (23) showed 
that mice passively immunized with anti-TNF antibody were protected 
from a normally lethal dose of LPS. In 1986, Tracey et al. (168) reported 
that treatment of rats with recombinant TNF induced lesions consistent 
with those caused by lethal doses of LPS. Subsequently, Tracey et al. 
(169) reported that anti-TNF antibody would protect baboons from a 
lethal bacteremic shock induced by a LD 1oo dose of live E. colL This 
supported evidence that TNF was a m ediator of endotoxin induced 
lethality (85, 169). 
Macrophages stimulated with LPS h ave also been shown to secrete 
interferon (66). It should be noted that lymphocytes (T cells) and 
leukocytes are the primary sources of interferon (80, 84). Interferon is a 
15,000-17,000 KDa glycoprotein that functions as an anti-viral agent, 
slows the growth of tumors, activates macrophages and n eutrophils, 
enhances the activity of natural killer cells (46). and induces enhanced 
expression of Ia antigens (69, 184). Interferon was also reported to 
prime macrophage for the induction of TNF and IL 1 by LPS (26, 41, 59). 
Billiau suggested that interferon was very important in the Shwartzman 
reaction (27, 154). It has been shown that IL 1 and TNF without 
interferon could cause portions of the Shwartzman reaction but not the 
complete syndrome (27). 
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Macrophages can function as effector cells against tumor cell targets 
when stimulated with LPS (3, 133). The tumoricidal activity was 
observed without Tor B cell help (47, 145, 178). It has been 
established that macrophage can kill tumor cells when primed with 
interferon and then given a second signal, namely LPS (51, 103, 134). 
There has been some controversy as to whether the tumoricidal activity 
was caused by the macrophage directly (i.e., cell-cell contact) or by a 
released toxic factor (i.e., cytotoxin or TNF) (97, 164). Suzuki et al. 
(164) reported on the gamma-interferon induced anti-tumor cytotoxic 
activity against a TNF-sensitive cell line suggesting that activated 
macrophages have tumoricidal activity of their own. Subsequently, a 
report from that laboratory indicated a synergistic effect caused by 
interferon, TNF and IL 1 to induce the macrophage tumoricidal activity 
(35). 
Other cell types besides macrophages, B cells, and T cells are 
affected by LPS. As mentioned above, natural killer cells are activated to 
be cytotoxic (46). Endothelial cells have the capacity to produce 
prostaglandin mediators, leading to shock and disseminated 
intravascular coagulopathy (120). Lipopolysaccharide has been shown to 
bind to neutrophils stimulating enhanced phagocytic activity, glycolysis, 
and an increased reduction of nitroblue tetrazolium (120). After 
administration of LPS a leukopenia is observed followed by a leukocytosis 
showing the change in neutrophil populations (10, 101). Platelets have a 
high affinity for LPS as shown by the the uptake of labeled endotoxin 
when injected in vivo (33, 50). In a review by McCartney and Wardlaw 
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(98), it was suggested that platelets could play a large role in 
endotoxemia due to release of platelet contents by LPS stimulation. 
Lipopolysaccharide has been shown to interact with serum proteins. 
in particular the proteins of the complement system (120). 
Lipopolysaccharide can activate the complement cascade by either the 
classical or by the alternative pathway (122) . C3 and other components 
of the complement system have been shown to mediate some of the 
pathology and toxicity associated with endotoxemia (120). For example, 
complement-LPS interactions lead to generation of anaphylotox:ins (C3a, 
C4a, C5a), chemotactic factors, and activation of the coagulation system 
(105, 107). 
The coagulation system has an intrinsic and extrinsic pathway for 
activation ( 120). Lipopolysaccharide has been shown to activate 
Hageman Factor (116), the first component of the intrinsic pathway, as 
well as kalllkrein, which can initiate fibrinolysis (140). The extrinsic 
pathway is activated by secretory products of monocytes, which as 
described above are very receptive to LPS stimulation (98). In severe 
cases of endotoxemia, disseminated intravascular coagulation (DIC) 
occurs leading to shock and ultimately death. 
The evolution of the clotting system from the lower animals to the 
higher animals has some similarities. The clotting system is a 
containment mechanism for infection. Levin and Bang (87) developed a 
clotting system to measure LPS activity using the cytosol of amebocytes 
of Limulus polyphemus, a horseshoe crab. In the presence of Ca++, LPS 
acts on a proenzyme to initiate the gelation of the substrate (98). This 
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assay was reported to be sensitive to 0.1 ng/ml LPS and is available as a 
chromogenic assay (123, 152). 
Endotoxin-induced lethality of mice is a common assay used when 
characterizing LPS (54). The relative toxicity of LPS is often measured 
in vivo by the determination of the mean lethal dose (LD50) for mice. 
Various models have been developed using chemicals such as lead 
acetate (153), actinomycin D (18), and D-galactosamine (54) to increase 
the sensitivity of animals to LPS several thousand fold (29) . In 1979, 
Bradley suggested a mechanism to explain LPS toxicity (29) . 
Lipopolysacchartde is endocytosed by the phagocyte and transported to 
the mitochondria where LPS affects the proton gradient causing ADP and 
NAPH to pool in the cytosol of the cell. The accumulation of these 
compounds causes an increased glycolysis inducing lysosomal release 
and proteolysis which leads to cell destruction. With the release of the 
cellular contents (i.e., lysosomal hydrolases, prostaglandins) symptoms of 
endotoxemia will develop leading to shock. DIC, and death unless the 
body can recover from the ensuing damage (29) . 
There are two Treponema species which colonize the colon and 
cecum of swine. These spirochetes are gram negative, ..6 hemolytic, 
anaerobic organisms (64, 63) that have a DNA G+C ratio of 25-28% 
(106) . One of these species, T. hyodysenteriae, was shown to be 
pathogenic for swine (64, 167) and the other species. T. innocens. was 
reported as a non-pathogenic organism isolated from normal swine colon 
(79). The differentiation between the two species is based on the strong 
..6 hemolysis produced by T. hyodysenteriae versus the weak beta-
15 
hemolysis seen with T. innocens (78). In addition, biochemical 
identification by hydrolase activity, using an API-2YME kit, has been 
reported (70). Enteropathogenicity in mice is a third criterion used to 
distinguish pathogenic from non-pathogenic species (130). 
Swine dysentery was first described in 1921 by Whiting et al. (182); 
however, it was 50 years later that Taylor and Alexander (167) and 
Harris et al. (64) described T. hyodysenteriae as the causitive agent of 
swine dysentery. Swine dysentery is characterized as a muco-
hemorrhagic diarrhea of 6-20 week old feeder pigs. Incubation periods 
ranging from 2 days to 3 months in naturally infected pigs (62). The 
mortality and morbidity due to swine dysentery can be high (i.e., greater 
than 50%) in untreated h erds (125) . 
The lesions of swine dysentery are described as a catarrhal, 
necrotic, hemorrhagic colitis confined to the cecum and large intestine 
of the pig (60). In addition to the presence of blood and excess mucus, 
fibrin and denuded epithelium are often seen on the colonic surface (2, 
60). 
Swine dysentery is not a secretory diarrhea but an absorptive defect 
where water and ions from the colonic contents are not adsorbed 
leading to dehydration. The blood-to-lumen flux of Na+ ions and Cl- ions 
are not changed following infection (9, 150). This differs from diarrhea 
caused by E. coli where the blood-to-lumen flow of fluids and ions far 
exceeds the absorbtive capacity of the colon (9). 
The two virulence factors attributed to T. hyodysenteriae are the 
hemolysin and the lipopolysaccharide (LPS). The hemolysin was 
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characterized as a lipoprotein with a molecular weight of 19,000 daltons 
(77). oxygen resistant, heat labile at 60°C, and was stable over a large 
range of pH values (148) . Both T. hyodysenteriae and T. innocens has 
hemolysin. The two hemolysins differ due to sensitivity of T. innocens 
hemolysin to cardiolipin ( 14 7) T. hyodysenteriae hemolysin had no 
cytolytic action on either prokaryotic or eukaryotic cells. The hemolysin 
lacked any mitogenic activity but decreased the mitogenic response of 
concanavalin A or E. coli LPS when combined in the assay ( 146). Saheb 
et al. (146) suggested this decrease in the mitogenic response may have 
been due to inactivation of macrophage or inhibition of the mitogens. 
Kent and Lemcke (77) injected rat ileal loops with the hemolysin 
from T. hyodysenteriae and induced fluid accumulation, desquamation of 
epithelial cells, hemorrhage, and neutrophil accumulation. These 
authors suggested that the hemolysin may contribute to the 
pathogenicity of T. hyodysenteriae (77). When the hemolysin of T. 
hyodysenteriae was added to various porcine cells, fibroblasts were 
affected more than epithelial cells and porcine lymphocytes were more 
sensitive to the cytotoxic effects than porcine macrophages and 
neutrophils (77). 
Lipopolysaccharide has also been described as a virulence attribute 
of T. hyodysenteriae (130). Nuessen et al. (128) reported that the 
treponemal LPS was toxic for murine peritoneal macrophages and 
enhanced both complement (C3) and immunoglobulin G-Fc receptor-
mediated phagocytosis. It was also shown that the treponemal LPS was 
mitogenic for murine spleen cells, and stimula ted chemotaxis of porcine 
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leukocytes (128). Additionally, Nuessen et al. (130) reported that 
treponemal LPS was lethal for actinomycin D-treated C3HeB/FeJ mice 
but not for LPS-hyporesponsive C3H/HeJ mice. Following infection with 
T. hyodysenteriae, it was shown that the LPS-hyporesponsive C3H/HeJ 
mice failed to develop lesions, suggesting that responsiveness to LPS was 
required for pathogenesis to occur (130) . Nuessen and Joens (129) 
demonstrated serotype specific opsinization of the treponemal organism 
with convalescent serum and suggested that LPS could serve as a 
protective antigen. 
T. hyodysenteriae has been subdivided into seven serotypes based on 
the presence of lipopolysaccharide ( 11 , 94) . The serotypes are 
represented by the following strains of T. hyodysenteriae: B234, 
serotype l; B204, serotype 2; Bl69, serotype 3; A-1, serotype 4; 
B8044, serotype 5; B6933, serotype 6; Ack 300/8, serotype 7. Lemke 
and Bew (86) have also described three additional serogroups, which 
have not been compared to the previously listed serogroups. 
As mentioned earlier, most of the work in LPS research has been 
with Enterobacteriacae LPS. There are numerous reports that show a 
wide variety of chemical forms and biologic activities between genera 
and species of LPS (98). 
Coxiella burnetii. the etiologic agent of Q fever, has a host-controlled 
phase variation that regulates the virulent and nonvirulent form of the 
organism ( 160) . The virulent phase 1 organism has a smooth LPS that 
was 100 to 1000 times less toxic than E. coli LPS or Salmonella typhi 
LPS (4). The endotoxin toxicity was associated with the Lipid A portion 
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of the C. burnetii LPS (4). Joshi and Banerjee showed the phase I LPS 
was pyrogenic, caused weight loss, as well as many other biologic effects 
associated with LPS activity (7 4). The LPS-induced symptoms were 
similar to the bacterial infection; however, though the LPS-induced 
condition was accelerated, it was of shorter duration (74). 
Chlamydia psittaci, an obligate intracellular parasite, has a rough LPS 
that was biologically inactive in comparison to E. coli LPS (toxicity, 
pyrogenicity and local Shwartzman reaction). but was mitogenic and 
stimulated prostaglandin E2 from peritoneal exudate cells (31 , 32). 
Brucella abortus, a bovine pathogen, has two types of LPS, a smooth 
LPS that extracts in the phenol phase, and a rough LPS found in the 
aqueous phase of a phenol/water extraction procedure (81). The lipid A 
is unique due to its presence in both the aqueous and phenol phase. 
This LPS was reported to be mitogenic in spleen cells from athymic 
nude mice as well as LPS-hyporesponsive C3H/HeJ mice (112, 158). 
Pseudomonas aeruginosa LPS has been reported as mitogenic, 
immunogenic, toxic for macrophage, but not lethal for LPS-
hyporesponsive C3H/HeJ mice (137). Reports of small structural 
differences between the LPS of P. aeruginosa and E. coli have been 
suggested as the cause of different biologic activities in the LPS-
hyporesponsive mice (137, 142). 
Bacteroides, Fusobacterium, and Veilonella species have LPS that are 
quite different from that of E. coli LPS (165). There is a loose 
association of lipid to polysaccharide with no detectable KDO or heptose 
sugars (67, 165). B. fragilis LPS was not lethal to chick embryos at 
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doses >200 µg while Neisseria meningititdis LPS was lethal at a dose of 
1.2 µg. A local Shwartzman reaction was not induced by B. fragilis LPS 
when 1000 µg was injected while Salmonella typhi LPS showed a good 
response at 3 µg (75). The lethality and pyrogenicity of the B. fragilis 
LPS were established at 1 % that of Salmonella lipid A (165). B . jragilis 
LPS was shown to be rnitogenic for LPS-hyporesponsive C3H/HeJ mice 
(73) as well as capable of stimulating murine splenocyte mitogenesis and 
polyclonal activity in LPS responsive mice (73, 177). 
Several spirochetes have also been shown to contain LPS with 
varying biologic activity. Vinh et al. (174) reported that Leptospira 
interrogans serovarcopenhageni LPS had similar morphological and 
chemical characteristics to Enterobacteriacae LPS except for the 
absence of KDO. Cinco et al. (37) compared L. interrogans and L. biflexa 
and observed a rough LPS containing KDO with similar SDS-PAGE 
profiles. Isogai et al. (71) compared the biologic activity of L. interrogans 
serovar copenhageni to E. coli LPS. They reported that the Leptospira 
LPS was less toxic for mice, was pyrogenic (without the biphasic curve 
seen with E. coli LPS). acted as an adjuvant, and capable of clotting the 
Limulus amebocyte lysate test (71). 
The presence of LPS in Borrelia burgdorferi has not been fully 
established due to conflicting reports (12, 166). In 1985 Beck et al. 
(12) reported that LPS constituted 1.5% of the total dry weight of B. 
burgdorferi and that the LPS had classical biologic activity (pyrogenicity, 
mitogenicity, clots Limulus amebocyte lysate, and was cytotoxic for 
murine macrophages). Habicht et al. (62) reported that a B. borgdorjeri 
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infection stimulated large quantities of IL 1 suggesting that the LPS 
could be the mediator for the cytokine production as well as playing an 
important role in the pathogenesis of Lyme disease . 
Takayama et al. (166) reported on the absence of a LPS from B. 
burgdorjerL They used a phenol/water extraction as well as a phenol-
chloroform-petroleum ether extraction to determine the absence of 
KDO, glucosamine, and hydroxy fatty acids by gas-liquid chromatography. 
They also studied prostaglandin E2 production and the formation of a 
clot by the Llmulus amebocyte lysate showing no response from the two 
preparations suggesting that there was no classic LPS in B. burgdorferi 
(166). 
Reports to date suggest that the LPS of T. hyodysenteriae plays a 
role in the pathogenicity of swine dysentery. The following reports 
examine the biologic activity of treponemal LPS in more detail and 
discuss the role of LPS in the pathogenesis of swine disease . 
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SECTION I. CLASSIC BIOLOGICAL RESPONSES INDUCED BY LPS AND 
ENDOTOXIN OF TREPONEMA HYODYSENTERIAE 
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ABSTRACT 
The chemical composition and classical biologic activities of 
lipopolysaccharide (LPS, phenol/water) and endotoxin (butanol/water) 
preparations from virulent Treponema hyodysenteriae and avirulent T. 
innocens were examined. The LPS and endotoxin preparations from T. 
hyodysenteriae strain B204 contained approximately 76% and 34% 
hexose, 0.12% and 0.45% 2-keto-3-deoxyoctanate (KDO). and 0.1 % and 
8% protein, respectively. The LPS and endotoxin preparations of T. 
innocens strain Bl 555a contained approximately 4 7% and 38% hexose , 
0.45% and 0.4% KDO, and 0.1 % and 26% protein, respectively. A 
silver stained 7.5 - 15% sodium dodecyl sulphate polyacrylamide gel 
showed approximatey 5 bands for the T. hyodysenteriae preparations 
while the T. innocens preparations failed to develop discrete bands 
upon electrophoresis. The Limulus amebocyte lysate assay determined 
that the treponemal preparations had comparable amounts of endotoxin 
activity when E. coli LPS was used as a standard. The LD50 of LPS and 
endotoxin from T. hyodysenteriae for BALB/cByJ mice was 380 µg and 
80 µg, respectively. The adjuvant activity, ability to induce a dermal 
Shwartzman reaction, and pyrogenicity of the treponemal preparations 
were very weak when compared to E. coli LPS. The treponemal LPS 
preparations were not mitogenic for murine spleen cells but the 
endotoxin preparations were very mitogenic. The results indicate no 
major difference in the biologic activity from the LPS and endotoxin of 
these Treponema species . 
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INTRODUCTION 
Lipopolysaccharide (LPS) is a molecule found in the outer 
membrane of gram negative bacteria and is associated with numerous 
biologic effects on the mammalian immune system (30, 35). These 
responses include B cell mitogenicity (12), polyclonal antibody 
induction (40), adjuvanticity (16). macrophage activation (1, 45, 46), 
immunogenicity (21), pyrogenicity (53), lethality (53), induction of 
tolerance (7, 23), and inflammatory reactions (47). 
Different extraction methods for LPS have been reported. A 
relatively pure LPS is extracted with the hot phenol/water method of 
Westphal and Jann (60). Endotoxin (LPS with the lipid-associated 
protein (LAP)) is extracted using either the trichloroacetic acid method 
of Boivin and Mesrobeanu (6), translated by Staub (50). or a 
butanol/water method of Morrison and Leive (33). Endotoxin possesses 
all of the aforementioned biologic activities, including stimulation of the 
LPS-hyporesponsive C3H/HeJ mouse strain (14, 59). The ability to 
stimulate C3H/HeJ mice has been shown to reside with the LAP of 
endotoxin (5, 14, 32, 48). 
In contrast to the Enterobacteriaceae, there are numerous gram 
negative organisms which have LPS with varying chemical and biologic 
characteristics (17, 31, 42, 49). For example, the LPS of Bacteroides 
fragilis was previously reported not to contain 2-keto-3-deoxyoctanate 
(KDO) (13), however, development of more sensitive tests has shown 
the presence of KDO (44). Additionally, little carbohydrate has been 
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detected in B. fragilis, but a long fatty acid composition that was quite 
divergent when compared to E. coli LPS (61). This LPS has the distinct 
difference from classical LPS in that it stimulates spleen cell 
mitogenesis from the LPS-hyporesponsive C3H/HeJ mouse strain (17, 
59). 
The gram negative spirochetes Leptospira interrogans and Borrelia 
burgdorferi possess rough types of LPS and have varying biologic effects 
on the host system when compared to those established for classical 
LPS (4, 8, 56). Treponema pallidum, the causitive agent of syphilis, was 
reported to contain LPS. but this molecule failed to elicit pyrogenic 
activity (41). 
Previous investigators have indicated that the LPS of T. 
hyodysenteriae is involved in the pathogenesis of swine dysentery (39). 
The LPS has been used to show serotype specificity for T. 
hyodysenteriae strains (3, 25). Nuessen and Joens (37) reported that 
trepomenal LPS was stimulatory for murine splenocyte mitogenesis, 
was toxic for murine macrophage, and was chemotactic for porcine 
neutrophils. To date, there have been no published studies comparing 
the LPS from T. hyodysenteriae and the LPS from T. innocens to 
determine the role of this molecule in virulence. 
Therefore. the objectives of the current study were to compare the 
biologic activities of LPS and endotoxin from T. hyodysenteriae and T. 
innocens. These activities were compared with those of classical E. coli 
LPS. The results indicate that the treponemal LPS preparations are 
much less active than E. coli LPS and that virulence of the two 
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treponemal species examined is not associated with the biologic 
function of LPS or endotoxin. 
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MATERIALS AND METHODS 
Anim als Original C3H/HeJ and BALBI cByJ breeder mice were 
obtained from Jackson Laboratory (Bar Harbor, ME), and C3H/HeN 
breeder pairs were obtained from Harlan Sprague Dawley (Madison, 
WI) . Mice were housed at the Laboratory Animal Resources (LAR) 
facility at the College of Veterinary Medicine, Iowa State University 
(ISU). Ames, IA. The mice were given autoclave sterilized water and 
feed (Purina Lab Chow #5010, Purina Mills, Inc. , St. Louis, MO) ad 
libitum. New Zealand White rabbits were obtained from Small Stock 
Industries (Pearidge, AR) and housed at LAR, ISU. 
Bacterial strains Treponema hyodysenteriae strain B204 and T. 
innocens strain Bl 555a were obtained from ISU. Escherichia coli 
strain K.235 was obtained from Dr. Suzanne Michalek, Department of 
Microbiology, University of Alabama in Birmingham. The Treponema 
species were grown in trypticase soy broth containing dextrose (BBL 
# 11 768, Cockeysville, MD) and supplemented with 5 g/l yeast extract 
(BBL). 20 ml of each VPI A and B salt solutions ( stock A - 0.4 g CaCh, 
0.4 g MgS04, 1 liter H20: stock B - 2 .0 g K2HP04, 2.0 g KH2P04, 20.0 g 
NaHC03, 1 liter H20) , and 0.5 g/l L-cysteine. Medium was adjusted to 
pH 7 .3. After autoclave sterilization, 50 ml/I horse serum (Hyclone 
Laboratories, Inc., Logan, UT) was added and cultures grown under 
anaerobic conditions (10% H2, 10% C02. 80% N2) for 18 - 24 hours. 
The cells were harvested by centrifugation at 10,000 x g for 20 
minutes, washed twice in phosphate buffered saline (PBS - 8 g NaCl, 
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1.15 g Na2HP04, 0.2 g KH2P04, to 1 liter H20. pH 7.2) and once in 
distilled water. Whole cells were frozen at -20°C until the LPS or 
endotoxin extraction was performed. 
LPS and endotoxin extraction Lipopolysaccharide was extracted 
by a modified hot phenol/water extraction procedure (3, 60). Briefly, 
200 mg of lyophilized whole cells were suspended in 10 ml water and 
mixed with an equal volume of liquified phenol at 68°C. The mixture 
was stirred for 15 minutes at 68°C. After cooling, the mixture was 
centrifuged at 200 x g to separate the two phases. The aqueous phase 
was collected and saved and the phenol phase was extracted twice with 
half the original volume of water. The aqueous phases were pooled and 
dialyzed exhaustively against distilled water. The LPS containing 
material was concentrated and then centrifuged at 100,000 x g for four 
hours. The pellet was resuspended in pyrogen-free water and the 
centrifugation was repeated two times . After the last centrifugation, 
the pellet was resuspended in pyrogen-free water and lyophylized. The 
LPS was stored at -20°C until used. Esherichia coli strain K235 LPS 
was prepared by the Westphal and Jann method (60). 
Endotoxin was prepared by the butanol/water extraction procedure 
(33). Briefly, 250 mg wet weight of whole cell paste was suspended in 
1 ml water and then 1 ml of butanol added. The endotoxin partitioned 
to the aqueous phase below the butanol. The butanol phase was 
extracted with half the original volume of water three times. The 
pooled aqueous phase was digested with Pronase (20 µg/ml final 
concentration) in 0 .2 M Na3P04 buffer (pH 7.0) overnight at 37°C. The 
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d igested endotox:in pr eparation was centrifuged at 10,000 x g for 40 
minutes and the precipitated interphase removed. The endotox:in 
solution was exhaustively dialyzed, concentrated, lyophylized, and 
stored at -20°C until assays were performed. 
The LPS and en dotox:in preparations were dissolved in pyrogen-
free saline and sterilized by heating to 100°C for 10 minutes. These 
solution s were stored at 4 °C until use. The preparations were heated 
for 1 - 2 minutes at 100°C before use in assays. 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) LPS and endotoxin were analyzed by SDS-PAGE as 
described by Laemmli (20). using a 1 mm, 7.5 - 15% acrylamide 
separating gel with a 4% stacking gel. The gel was electrophoresed at 
35 mA per gel (Model SE600, Hoeffer Sientific Instruments. San 
Francisco, CA) for 2 - 3 hours until the dye front was 1 cm from the 
bottom of the gel. The LPS and endotox:in samples were visualized by 
the silver stain procedure of Tsai and Frasch (55) or a Coomaisse blue 
stain (Kodak R-250) (9) . 
Chemical determination The protein content of the LPS and 
endotoxins were measured as described by Lowry et al. (24) with bovine 
serum albumin as a standard. 
Carbohydrate content was determined by phenol-H2S04 method 
(2). Briefly, the a liquots of LPS were p laced into acid cleaned 13 x 100 
mm glass tubes with 50 µl of 80% phenol added to each tube. Five ml 
of H2S04 was added to each tube. The tubes were incubated 30 
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minutes at room temperature before reading adsorbance at 485 nm. D-
glucose was used as the carbohydrate standard. 
2-keto-3-deoxyoctonate (KDO) content was determined by the 
thiobarbituric acid procedure of Karkhanis et al. (18). 
Mitogenesis Mitogenesis was performed by inoculating 5 x 105 
murine splenocytes/well of a 96 well microtiter plate (Costar #3799, St. 
Louis, MO) in RPMI 1640 supplemented with 10 mM HEPES, 25 
units/ml penicillin, 25 µg/ml streptomycin, and 20 mM L-glutamine. 
Various concentrations of LPS or endotoxin were added to the 
appropriate wells. Cultures were incubated for 48 hours at 37°C in 5% 
C02 in air. Cultures were pulsed with 0.5µC 3H-methyl-thymidine 
(Amersham Corp., Arlington Heights, IL) during the final 8 hours of 
incubation. Cells were harvested onto filter paper discs using a 
microharvester (Bellco, Vineland, NJ), dried and counted using liquid 
scintillation. Cultures were performed in triplicate and results are 
expressed as the stimulation index (experimental CPM/ control CPM) 
(59). 
Lethality BALB/cByJ mice sensitized with galactosamine (22) were 
used to determine the relative toxicity of the treponemal LPS and 
endotoxin and the 50% lethal dose (LD50) was determined by the 
method of Reed and Muench (43). Briefly, the mice were provided 
with drinking water containing 2 mg/ml galactosamine ad libitum for 
48 hours. Mice were then given an intraperitoneal injection (i.p.) of 16 
µg galactosamine followed by an intravenous injection (i.v.) injection of 
the indicated dose of LPS or endotoxin. The assay was set up with 5 
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mice per group u sing 5 different concentrations of LPS or endotoxin. 
Mice were observed for 2 days and deaths recorded. 
Limulus amebocyte lysate assay (LAL) A chromogenic LAL assay 
(QCL-1000 Whittaker M.A. Bioproducts, Walkersville, MD) was 
performed as described by the manufacturer. 
Adjuvanticity Both in vivo (59) and in vitro (26) assays were used 
to determine adjuvant activity of the stimulants. In vivo, BALB/cByJ 
mice were given an interperitoneal injection of a suboptimal dose of 
sheep red blood cells (SRBC, 0.5%). Mice were simultaneously treated 
i.p. with either LPS or endotoxin at the indicated doses. After 4 days, 
mice were sacrificed by cervical dislocation, spleens were removed, 
minced, washed in Hank's balanced salt solution, and resuspended. 
The anti-SRBC plaque forming cell (PFC) response was determined 
using the Cunningham slide method (26) . 
The in vitro immune response to SRBC was examined using 
spleens from BALBI cByJ and C3H/HeN mice, previously primed with 
0.05% SRBC i.p. 3 days earlier. Mice were sacrificed and the spleens 
were aseptically removed, minced, the cells were washed and 
resuspended to 1 x 107 cells/ml in minimal essential medium (MEM) 
supplemented with 37 µg/ml NaHC03, 67 µg/ml gentamycin, 2 mM L-
glutamine, 1 mM sodium pyruvate, 0 .1 mM nonessential amino acids, 5 
x 10-2 mM 2-mercaptoethanol, and 10% fetal calf serum (FCS, JR 
Scientific, Irvine, CA). One half ml of cell suspension was added to each 
well of a 24 well cluster dish (Costar #3424, Cambridge, MA). Thirty µl 
of a 1 % SRBC suspension (5 ml of 10% washed SRBC in glucose (0.5 
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mg/ml)-PBS treated with neuraminadase (0.01 unit/ml) for 1 hour at 
37°C) (30) in HBSS were added to all wells except controls. LPS or 
endotoxin was added at the indicated concentrations. Cultures were 
incubated for 5 days at 37°C in modular inculator chambers (Billups-
Rothenberg, Del Mar, CA) flushed with a 7% 02. 10% C02, 83% N2 gas 
mixture. Cultures were fed daily with 1 drop of a Mishell-Dutton 
feeding cocktail (18.0 ml Hanks Balanced salt solution (lOx) , 20 ml of a 
0.1 g dextrose/ml HBSS, 8 ml MEM amino acid solution (50x), 4 ml 
nonessential amino acid (lOOx), 4 ml 200 mM L-glutamine, 15 ml 7.5% 
NaHC03, 0.6 ml gentamycin (50 mg/ml). supplemented with fetal calf 
serum (33% final concentration)). Cultures were harvested on day 5 and 
assayed for the anti-SRBC PFC response performed as described above. 
Pyrogenicity New Zealand White rabbits (3 - 4 kg) were injected 
with LPS or endotoxin i.v. in the marginal ear vein at the indicated dose 
in 0.5 ml pyrogen-free saline. Rectal temperatures were taken every 15 
- 20 minutes with a digital thermometer (Norelco, Stamford, CT). 
Dermal Shwartzman reaction New Zealand White rabbits weighing 
3 - 4 kg had their backs shaved 24 hours prior to receiving preparative 
intradermal injections (i.d.) of LPS or endotoxin in 0.1 ml. Twenty-four 
hours after the preparative administration, 50 µg E. coli LPS in 0.2 ml 
pyrogen-free saline was given i.v. in the marginal ear vein (provocative 
dose). The dermal injection sites were observed at 24, 30, and 48 
hours for induration, erythema and necrosis. Animals were euthaniZed 
at 48 hours and tissue was taken for routine histologic examination 
(hematoxyalin and eosin staining) ( 19). 
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Reagents Unless stated otherwise, all reagents and chemicals 
were obtained from Sigma Chemical Company, St. Louis, MO. 
Statistics The results are expressed as the mean ± S.E.M. where 
applicable, and significance was determined using the student t test. 
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RESULTS 
Chemical analysis of LPS and endotoxin The chemical analyses 
shown in Table 1 indicate that the treponemal LPS preparations 
containing negligible protein and a large percentage of carbohydrate 
(almost 80% for T. hyodysenteriae and 47% for T. innocens). The 
endotoxins had a larger amount of protein than the LPS preparations. 
The carbohydrate content was similar in 3 of the 4 preparations 
examined (Table 1) while the T. hyodysenteriae LPS contained almost 
twice the amount of carbohydrate in comparison to other preparations. 
The KDO content was determined to be approximately 0.4 - 0.45 % 
except in the T. hyodysenteriae LPS where the amount was 
approximately 0.12 %. 
TABLE 1. Chemical analysis of treponemal LPS and endotoxin 
T. hyodysenteriae T. innocens 
Component LPS Endo toxin LPS Endotoxin 
Protein (%) <0.la 8 <0.1 26 
Hexose (%) 76 34 47 38 
KDO (%) 0.12 0.45 0.45 0.4 
avalues are expressed as percent weight (w/w). 
SDS-PAGE Silver stained polyacrylamide gels (Fig. lA) showed a 
distinct profile with 5 bands for the T. hyodysenteriae LPS and an 
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unresolved profile for the T. innocens LPS. As can be seen in Figure 
IA.Jane E, the T. innocens LPS failed to resolve into distinct bands or a 
"tiger tail" pattern as is associated with the enteric LPS (lane B). 
However, T. innocens endotoxin (lane F) did resolve into distinct bands 
but failed to migrate into the gel as far as either the T. hyodysenteriae 
or E. coli preparations. Coomaisse blue stained gels (Fig. lB) showed a 
major protein band with an apparent molecular weight of 35 - 40 kDa 
in both T. hyodysenteriae and T. innocens endotoxin preparations. T. 
innocens endotoxin also showed 3 minor protein bands (Fig. 1 B, lane 
F). 
Mitogenic response Treponemal endotoxins were observed as 
very potent mitogens of BALB/cByJ spleen cells (Fig. 2). The 
treponemal LPS preparations failed to stimulate a measurable 
mitogenic response. In contrast to the lack of a response induced by 
treponemal LPS, the treponemal endotoxin preparations stimulated a 
mitogenic response in LPS-hyporesponsive C3H/HeJ mice (data not 
shown). 
Endotoxin activity The relative toxicity of LPS and endotoxin 
preparations has been examined by mouse lethality. The LD50 of T. 
hyodysenteriae LPS and endotoxin was determined to be 350 µg/mouse 
and 80 µg/mouse, respectively (data not shown). This is in comparison 
to E. coli strain K235 LPS which was previously determined to have an 
LD50 of 0.6 µg/mouse (59). 
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Electrophoretic separation of LPS and endotoxin from T. 
hyodysenteriae strain B204 and T. innocens strain Bl555a were 
performed on a 7.5 - 15% separating gel. The LPS and 
endotoxin were visualized by silver staining (A) and by 
Coomaisse blue staining (B). Lane A., molecular weight 
standard; B., E. coli LPS, 20 µg; C., B204 LPS, 80 µg; D., B204 
endotoxin, 40 µg; E., Bl555a LPS, 40 µg; F., Bl555a endotoxin, 
40 µg. Molecular weight determinations (K.Da) are indicated on 
left side of panel A and the right side of panel B. 
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Limulus amebocyte lysate assay The LAL assay indicated that the 
treponemal preparations had endotoxin units/ng comparable to 
standard E. coli LPS. It was determined there were 1.2 and 1.4 units 
endotoxin activity per ng T. hyodysenteriae LPS and endotoxin, 
respectively. T. innocens LPS and endotoxin had 0.2 and 2.4 units of 
endotoxin activity per ng. This was compared to the 1.2 units of 
endotoxin activity per ng of E. coli K235 LPS. 
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FIG. 2. Mitogenic responses of BALBI cByJ splenocytes stimulated by 
treponemal LPS or endotoxin. The assay was measured by 3H-
thymidine incorporation. A.) T. hyodysenteriae B204 LPS 
(triangle); B204 endotoxin (square); E. coli LPS (x); B.) T. 
innocens B l 555a LPS (triangle); Bl555a endotoxin (square); 
and E . coli LPS (x). Values from triplicate cultures are 
expr essed as a stimulation index (S.I.) defined as the 
experimental CPM/ control CPM (E/C). 
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Adjuvanticlty The adjuvant activity of LPS and endotoxin from 
both Treponema species was determined in vitro (Fig. 3) and in vivo 
(Fig. 4) using SRBCs as the test antigen. The results depicted in Figure 
3 demonstrate that the treponemal LPS was a weak adjuvant in 
comparison to E. coli LPS or the treponemal endotoxins. In the in vivo 
test (Fig. 4), the T . hyodysenteriae preparations at 100 µg/mouse did 
not enhance PFC response as well as E.coli LPS at 10 µg/mouse. 
Pyrogenlclty Rabbits were injected with SO, 100, and 2SO µg of 
the treponemal LPS or endotoxin. The results presented in Figure S 
demonstrated that 2SO µg of the treponemal preparartions were less 
pyrogenic than 10 µg of E. coli LPS. A mild febrile response was noted 
in rabbits treated with the T. hyodysenteriae endotoxin (Fig. SA). 
Niether the LPS or endotoxin preparartion of T. innocens were 
pyrogenic (Fig. SB). There was no pyrogenic response observed in 
rabbits receiving SO or 100 µg of the treponemal preparations (data not 
shown). 
Local Shwartzman reaction Gross lesions induced by LPS and 
endotoxin of the Treponema species were either nonexistent or 
consisted of very mild edema and erythema, while the E. coli LPS 
induced a necrotic lesion (Fig. 6). Hematoxylin-eosin staining of 
sections treated with T . hyodysenteriae endotoxin (SOO µg) as the 
preparatory treatment and E. coli LPS as the provocative dose showed a 
mild cellular response with some edema. At SOO µg, the T. innocens 
endotoxin induced a response with multifocal areas of inflammatory 
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cells. No lesions were observed on sites inoculated with the 
treponemal LPS preparations. 
Experiments were performed using either E. coli LPS or T. 
hyodysenteriae LPS as the provocative dose for the Shwartzman 
reaction with no difference in the resulting responses (data not shown). 
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FIG. 3. In vitro anti-SRBC PFC response. To measure adjuvant activity, 
C3H/HeN murine splenocytes were treated with 30 µl of 10% 
SRBCs with the indicated dose of treponemal LPS or endotoxin. 
On day 5, the anti-SRBC PFC response was measured. A.) T. 
hyodysenteriae strain B204; B.) T. innocens strain Bl555a: 
LPS (open bars): endotoxin (shaded bars): SRBC alone, (single 
star); and SRBC plus 10 µg E. coli LPS (two stars). Values are 
expressed as the mean + S.E.M. anti-SRBC PFCs per million 
splenocytes from triplicate cultures. 
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FIG. 4. The in vivo adjuvant activity of T. hyodysenteriae preparations 
were determined by injecting BALB/cByJ mice i.p. with 0.2 ml 
of a 0 .5% SRBC suspension containing the indicated dose of 
LPS or endotoxin. On day 4, anti-SRBC PFC responses were 
determined. 10% SRBC (open bar); 0.5% SRBC (closed bar); 
E. coli LPS plus 0 .5% SRBC (shaded bar); T. hyodysenteriae 
strain B204 LPS plus 0.5% SRBC (hatched bar); B204 
endotoxin plus 0.5% SRBC (horizontal hatched bar). Values are 
expressed as the mean± S .E.M. anti-SRBC PFC response per 
million splenocytes using 5 mice per group. 
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FIG. 5. Rectal temperatures of rabbits stimulated with LPS or endotoxin 
of Treponema species were measured. The results are 
expressed as the average change in temperature of 2 rabbits 
followin g t reatment with either 250 µg of a treponemal 
preparation or 10 µg of E. coli LPS (square). A.) T. 
h yodysenter iae B204 LPS (circle); B204 endotoxin (triangle); 
B.) T. innocens B l 555a LPS (circle); Bl555a endotoxin 
(triangle). 
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FIG. 6. Dermal Shwartzman reaction. Rabbits received an i.d. injection 
of LPS or endotoxin from each treponemal species. Two groups 
(two rabbits/ group) were given an i.v. injection in the marginal 
ear vein of either T. hyodysenteriae endotoxin or E. coli LPS. 
The rabbit depicted received 50 µg of E. coli LPS i.v. 20 hours 
after i.d. injections. The injection pattern from left to right on 
the top row was E.coli LPS (100 µg), T. hyodysenteriae LPS 
( 100 µg), Bacteroides fragilis LPS ( 100 µg); bottom row was 
saline, T. hyodysenteriae endotoxin (250 µg), T. hyodysenteriae 
LPS (250 µg). 
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DISCUSSION 
Lipopolysaccharide of T. hyodysenteriae has been previously 
isolated and characterized as containing 85 - 90% carbohydrate and 5 -
10% protein (3). The use of treponemal LPS and rabbit anti-serum 
established seven serotypes (3, 25). A study of the biologic activity of T. 
hyodysenteriae strain B204 LPS reported the preparation to be 
mitogenic, toxic, and enhanced phagocytosis (37). Nuessen and Joens 
(38) demonstrated that the LPS was responsible for the serotype-
specific opsonization of T. hyodysenteriae using convalescent pig serum. 
Additionally, Nuessen et al. (39) reported that the LPS of T. 
hyodysenteriae was lethal to C3HeB/FeJ mice but not for LPS-
hyporesponsive C3H/HeJ mice, and was chemotactic for murine 
macrophage. These papers suggested that the LPS of T. hyodysenteriae 
had biologic activity and played a role in the pathogenesis of swine 
dysentery. 
Other spirochetes, besides T. hyodysenteriae, have been shown to 
contain LPS (4, 8, 15, 29, 56). Mergenhagen et al. (29) demonstrated 
the presence of endotoxin in B. buccalis and B. vincentii. The presence 
of LPS has also been reported in B. burgdorferi, the Lyme disease 
spirochete (4). B. burgdorferi LPS was pyrogenic, mitogenic, and 
clotted the LAL (4). However, Takayama et al. (54) have challenged the 
existence of LPS in B. burgdorferi since they were unable to 
demonstrate the presence of LPS in either a phenol/water extract or a 
phenol/chloroform/petroleum ether extract of the organism. This 
conclusion was based on the inability to detect KDO, glucosamine, and 
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hydroxy fatty acids in the phenol/water extracts or the ability of the 
preparations to induce either prostaglandin E2 production or gelation 
of the LAL (54). 
Isogai et al. (15) and Vinh et al. (56) have isolated LPS from 
Leptospira interrogans. The L. interrogans LPS was shown to be toxic 
for mice and produced a febrile response in rabbits but neither 
response was comparable to the responses obtained with E. coli LPS 
(15). The leptospiral LPS also induced adjuvant activity, induced clot 
formation in the LAL, and caused bone marrow and liver necrosis in 
treated mice (15). Vinh et al. (56) determined that the fatty acid 
composition of LPS from L. interrogans consisted of hydroxylauric 
(C12:ol. palmitic (Crn:ol. and oleic acid (C18:1) without any C14 fatty acids 
(i.e., myristic acid (C14:0) and 3-hydroxymyristic acid (3-0H-C14:0D (56). 
They also demonstrated that the L. interrogans LPS contained an 
unusual form of KDO (56). In contrast to Takayama et al. (54), the 
biochemical and biological information indicate the presence of an LPS-
like molecule in L. interrogans. 
In the present study, the treponemal LPS preparations (Table 1) 
were shown to have a negligible protein component, while the T. 
innocens and T. hyodysenteriae endotoxin preparations contained 26% 
and 8% protein, respectively. The presence of protein in the 
endotox:in preparations was expected due to the nature of the 
butanol/water extraction procedure (33, 51, 57, 58). However, the 
three-fold difference in protein content between the endotox:in 
preparations was not understood. The carbohydrate content of the T. 
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hyodysenteriae LPS was similiar to that reported previously by Baum 
and Joens (76% and 89%, respectively) (3). As expected, treponemal 
endotoxins had a smaller proportion of carbohydrate than the LPS 
preparations due to the increase in the protein content in the sample. 
The KDO content (0.4 - 0.45%) was similiar in 3 of the 4 treponemal 
preparations. However, the KDO content (0.12%) of T. hyodysenteriae 
strain B204 LPS was almost four times less than the other preparations. 
These differences may be due to the physicochemical nature of the 
molecule extracted by phenol/water vs. butanol/water techniques 
and/or the differences between species of Treponema. Using gas-liquid 
chromatography, the LPS of T. hyodysenteriae was shown to contain 14 
and 16 carbon fatty acids, glucosamine, KDO, heptose, rhaminose, 
mannose, galactose and glucose (personal communication, Dr. Hyoik 
Ryu, Veterinary Microbiology and Preventive Medicine, Iowa State 
University). In addition, mild acid hydrolysis of treponemal LPS 
preparations yielded a water insoluble precipitate similar to that 
obtained from E. coli LPS (11). Collectively, these results indicate that 
the phenol/ water preparations from T. hyodysenteriae contain LPS-like 
molecules. 
The LAL assay has been used to measure endotoxin activity, but not 
quantity, in biological materials (28). This assay demonstrated that the 
treponemal preparations had endotoxic activity comparable to E. coli 
LPS. 
Treponemal preparations were analyzed by SDS-PAGE and two 
different profiles were obtained for the T. hyodysenteriae and T. 
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innocens preparations (Fig. 1). In comparison to the T. hyodysenteriae 
LPS (Fig. lA, lane C), the T. innocens LPS (Fig. lA, lane E) did not 
migrate as far into the gel and did not resolve into distinct bands. The 
endotoxin preparation of T. innocens was also less mobile in the gel but 
did resolve into numerous bands (Fig. lA, lane F). These observations 
may be related to the differences in lipid content previously reported 
by Matthews et al. (27) . However, these apparent physicochemical 
differences did not result in varying biologic activities between the T. 
hyodysenteriae and T. innocens preparations. 
Even though the treponemal LPS preparations were not mitogenic, 
the endotoxin preparations from both T. hyodysenteriae and T. 
innocens induced substantial mitogenic responses in murine 
splenocytes (Fig. 2). These results are in contrast to a previous report 
in which T. hyodysenteriae LPS was shown to be mitogenic (37). 
However, the protein content of the LPS preparation was reported as 
8% (37) and this would be consistent with the endotoxin preparations 
used in the present study. The protein component(s) of endotoxin 
preparations have been shown to be mitogenic (52). This would 
suggest that the protein and not the lipid A component of the 
endotoxin complex from the Treponema species was the major 
mitogenic moiety. 
In comparison to E. coli LPS (LD50 = 0.6 µg) (59). the T. 
hyodysenteriae B204 LPS (LD50 = 350 µg) and endotoxin (LD50 = 80 µg) 
were at least 100 times less toxic for galactosarnine treated mice. In 
addition to being mitogenic, the protein component of endotoxin 
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appeared to potentiate the toxicity of the LPS molecule. However, 
there is no reported evidence to suggest that the enterobacterial LAP or 
porin proteins are toxic (36). 
Endotoxin and LPS has adjuvant activity which non-specifically 
activates the immune response (44) . Adjuvant activity of the 
treponemal preparations were examined both in vitro (Fig. 3) and in 
vivo (Fig. 4). It was observed, in vitro, that T. hyodysenteriae LPS failed 
to induce an adjuvant response while the endotoxin did induce a 
significant adjuvant response at 2.5 µg per culture (Fig. 3A). The T. 
innocens LPS, like the T. hyodysenteriae LPS, was a poor adjuvant but 
the endotoxin preparation stimulated the anti-SRBC response at 25 µg 
per culture (Fig. 3B). In contrast to the in vitro data, LPS from T. 
hyodysenteriae as well as endotoxin (Fig. 4) induced in vivo adjuvant 
responses to SRBCs in vivo. However, the responses observed, even 
with 1 OOµg of LPS or endotoxin, were not as strong as the response 
obtained with 1 Oµg of E. coli LPS. As for the mitogenic activity, the 
enhanced adjuvant activity of the endotoxin preparations in vitro may be 
due to the presence of LAP or porins (52). 
Endotoxin and LPS may contribute to the pathogenesis of a disease 
by eliciting a pyrogenic response in the host. The ability of the 
treponemal preparations to elicit a febrile response in New Zealand 
White rabbits was examined (Fig. 5) . The endotoxins (250 µg/rabbit) of 
both species induced a slight but discernible biphasic febrile response 
in rabbits, while the LPS from both species failed to induce detectable 
febrile responses. Even though as much as 25 times the amount of E 
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coli LPS was given to the rabbits, the treponemal LPS preparations 
were not pyrogenic. The mild pyrogenic activity observed with the 
endotoxin preparations may have been associated with the protein 
component and/or their ability to stimulate endogenous pyrogens (i.e .. 
interleukin 1 and tumor necrosis factor (Fig. 1 and 3, pages 66 and 68, 
Section II)). 
A local Shwartzman reaction is often used as a measure of the 
relative toxicity of an endotoxic preparation. This response is observed 
in rabbits which have received an i.d. injection of LPS (priming dose) 
followed 18 - 24 hr later with an i.v. injection of LPS (provocative dose). 
Regardless of the source of the provocative dose, dermal necrosis was 
not observed when treponemal preparations were used as the priming 
dose (Fig. 6). However, a necrotic lesion was obtained when an E. coli 
LPS priming dose was followed by a T. hyodysenteriae endotoxin 
provocative dose (personal observation). The ability of the treponemal 
endotoxin to serve as the provocative but not the priming dose appears 
somewhat contradictory. The mechanisms by which a local 
Shwartzman reaction is induced are not clearly understood, but the 
activation of the host's coagulative enzymes and the deposition of fibrin 
thrombi in tissue play a major role in the development of necrotic 
lesions (35). The actions of the two injections are assumed to be the 
same; however, it is likely that the priming injection renders the host 
hyper-responsive to the provocative dose. The inability of the 
treponemal preparations to prime the rabbit for a local Shwartzman 
reaction would indicate that the host is not rendered hyper-responsive 
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and this would be consistent with the reduced toxicity and pyrogenicity 
observed. In addition, the ability of the treponemal preparations to 
provoke a Shwartzman reaction would be consistent with the ability of 
the treponemal preparations to gel the LAL. Even though the 
treponemal preparations are not as active as E. coli LPS, they do 
possess some endotoxic properties and may contribute to the 
development of lesions during infection with T. hyodysenteriae. 
In conclusion, the results indicated that the treponemal 
preparations were much less active than E. coli LPS in that the LPS of 
both treponemal species did not induce an inflammatory response, 
were not mitogenic, pyrogenic, or lethal even at high doses. In 
comparison to the LPS preparations, the endotox:ins were more toxic, 
were able to provoke a Shwartzman reaction, and induced good 
mitogenic responses. This suggested that the presence of protein 
renders the endotoxin complex biologically active or that the activity is 
due to the protein itself. Even though the role of LPS in the 
development of dysenteric lesions is not fully understood, the virulence 
or avirulence of T. hyodysenteriae and T. innocens can not be attributed 
solely to the biologic activity of LPS or endotoxin. 
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SECTION II. ABILI1Y OF TREPOMENAL LPS AND ENDOTOXIN TO 
INDUCE CYfOKINE RELEASE FROM LYMPHORETICULAR CELLS 
57 
ABSTRACT 
The biologic activity of lipopolysaccharide (LPS, phenol/water) and 
endotoxin (butanol/water) preparations from virulent Trepomena 
hyodysenteriae and avirulent T. innocens was examined . The 
treponemal preparations showed toxic activity on murine peritoneal 
exudate cells (PEC) though not at concentrations as low as E. coli LPS. 
Both treponemal LPS preparations showed no stimulatory activity for 
induction of interleukin 1 or tumor necrosis factor from PECs; 
however, the endotoxins did stimulate induction of these products but 
at doses 50 fold higher than E. coli LPS. Natural killer cell activity was 
augmented by treponemal endotoxin-treated mice. The T. innocens 
endotoxin augmented NK activity to levels equivalent to E. coli LPS. 
Suppression of the immune response was observed by the T. 
hyodysenteriae preparations. The results suggest that no major 
differences exist in the biologic activities between T. hyodysenteriae 
and T. innocens LPS or endotoxin. 
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INTRODUCTION 
Lipopolysacchartde (LPS) and endotoxin have been extensively 
studied and have been the subject of numerous review articles (i.e .. 4, 
23, 25, 26) . The biological effects attributed to LPS and endotoxin have 
been established using preparations isolated from Escherichia coli and 
Salmonella species. These molecules have multiple effects on the 
immune system which affect B lymphocytes, T lymphocytes, 
macrophages, as well as other cells of the body. Of these cells, 
macrophages play a major role in the immune system as antigen 
presenting cells (39). Macrophages also interact with lymphocytes, are 
highly bactericidal and tumoricidal, and secrete a wide range of 
bioactive molecules (39) . 
The list of cytokines secreted by macrophage is quite extensive. 
Stimulation and/or activation of macrophage causes production and 
secretion of interleukin 1 (IL 1) (21). tumor necrosis factor (TNF) (3). 
interferon (14), as well as other products such as collagenase, 
prostaglandins (1). and complement components (26). Through 
secretion of these cytokines, B cells are affected (26), T cells are 
induced to produce interleukin 2 (39). and natural killer cell activity is 
augmented (7b). Because of the numerous activities induced by the LPS 
molecule, many host defense mechanisms against gram negative 
bacteria are stimulated and aid in recovery from disease. For example, 
LPS induces fever which speeds up metabolism to fight an infection and 
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it can initiate the coagulation system which would contain an infection 
(26, 25). 
In addition to the Enterobacteriaceae there are numerous gram 
negative organisms which have LPS with varying biological and chemical 
characteristics. Some examples include Pseudomonas aureginosa (30), 
Bacteroides fragilis ( 1 7) , and Brucella abortus (22, 35). P. aureginosa 
has small structural differences in its LPS when compared to the 
enteric LPS but this LPS has biologic activity in the LPS-hyporesponsive 
C3H/HeJ mouse (30, 32). The LPS of B. fragilis contains KDO (31), 
heptoses, has little 0-specific polysaccharide, and has a fatty acid 
composition that is quite divergent when compared to E. coli LPS (42). 
B. abortus LPS is isolated from the phenol phase of a phenol/water 
extraction method (Westphal and Jann) (19). This LPS was different 
from classical LPS in that Brucella LPS stimulate spleen cell 
mitogenesis from LPS-hyporesponsive C3H/HeJ mice (22, 31, 32, 35, 
41). 
Spirochetes are also gram negative organisms. Leptospira 
interrogans and Borrelia burgdorjeri possess a rough type of LPS and 
induce varying biologic effects on the host immune system in 
comparison to E. coli LPS (2, 6, 40). L. interrogans LPS was reported 
to cause fever without a biphasic response, acted as an adjuvant, and 
was less lethal than E. coli LPS ( 15). B. burgdorf eri LPS was reported to 
be mitogenic, pyrogenic, clot the Limulus amebocyte lysate, and 
stimulate interleukin 1 production (2, 11). 
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Nuessen et al. (28) first implicated the LPS of Treponema 
hyodysenteriae as a virulence attribute in 1982. It was also reported 
that the LPS was toxic to murtne macrophages and enhanced both 
complement (C3) and immunoglobulin G-Fc receptor-mediated 
phagocytosis (28). Additionally, the LPS was mitogenic for murtne 
splenocytes and stimulated chemotaxis of porcine leukocytes (28). In 
1983, Nuessen et al. (29) reported that T . hyodysenteriae LPS was 
lethal for LPS-responsive mice but not for LPS-hyporesponsive 
C3H/HeJ mice. 
The present report compares the biologic activity of LPS and 
endotoxin extracted from T. hyodysenteriae and T. innocens. Results 
indicate that the treponemal LPS was toxic for murtne macrophages, a 
poor inducer of monokines, and failed to induce natural killer cell 
activity. However, the endotoxin preparations were often potent 
stirnulators of lymphoreticular cells, though no as potent as E. coli LPS. 
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MATERIALS AND METHODS 
Bacteria and cell lines Treponema hyodysenteriae strain B204 and 
T. innocens strain Bl555a were obtained from at Iowa State University 
(ISU), Ames, IA. Escher ichia coli strain K235 was obtained from Dr. 
Suzanne Michalek, Department of Microbiology, University of Alabama 
in Birmingham. The Treponema species were grown in trypticase soy 
broth containing dextrose (BBL #11768, Cockeysville, MD) and 
supplemented with 5 g/l yeast extract (BBL). 20 ml of each VPI A and B 
salt solutions ( stock A - 0.4 g CaCl2. 0.4 g MgS04, 1 liter H20: stock B 
- 2.0 g K2HP04, 2.0 g KH2P04, 20.0 g NaHC03, 1 liter H20). and 0.5 g/l 
L-cysteine. Medium was adjusted to pH 7 .3. After autoclave 
sterilization, 50 m l/l horse serum (Hyclone Laboratories, Inc., Logan, 
UT) was added and cultures grown under anaerobic conditions (10% 
H2. 10% C02. 80% N2) for 18 - 24 hours . The cells were harvested by 
centrifugation at 10,000 x g for 20 minutes. washed twice in phosphate 
buffered saline (PBS - 8 g NaCl, 1.15 g Na2HP04, 0.2 g KH2P04, to 1 
liter H20. pH 7.2) and once in distilled water. Whole cells were frozen 
at -20°C until the LPS or endotoxin extraction was performed. 
The cell lines used were purchased from the American Type 
Culture Collection and grown as prescribed. The IL 1 assay was run 
using the IL 1 dependent T helper cell clone Dl0.G4.l (TIB 224). The 
TNF assay used a TNF sensitive, murine fibrosarcoma cell line L929 
(CCL 1) (5). and to act as a target cell for the natural killer assay, YAC-1 
cells (TIB 160) were used. 
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Animals Original breeder pairs of C3H/HeJ and BALB/cByJ mice 
were obtained from Jackson Laboratory (Bar Harbor, ME). and 
C3H/HeN mice were obtained from Harlan Sprague Dawley (Madison, 
WI). Mice were housed at the Laboratory Animal Resources (I.AR) 
facility at the College of Veterinary Medicine. ISU. The mice were 
given autoclave-sterilized water and feed (Purina Lab Chow #5010, 
Purina Mills, Inc .. St. Louis, MO) ad libitUTTL 
LPS and endoto:rln e xtraction Lipopolysaccharide was extracted 
by a modified hot phenol/water extraction procedure (41). Briefly, 200 
mg of lyophillzed whole cells were suspended in 10 ml water and 
mixed with an equal volume of liquified phenol at 68°C. The mixture 
was stirred for 15 minutes at 68°C. After cooling, the mixture was 
centrifuged at 200 x g to separate the two phases. The aqueous phase 
was collected and saved and the phenol phase was extracted twice with 
half the original volume of water. The aqueous phases were pooled and 
dialyzed exhaustively against distilled water. The LPS containing 
material was concentrated and then centrifuged at 100,000 x g for four 
hours. The pellet was resuspended in pyrogen-free water and the 
centrifugation was repeated two times. After the last centrifugation, 
the pellet was resuspended in pyrogen-free water and lyophylized. The 
LPS was stored at -20°C until used. E.coli strain K.235 LPS was 
prepared by the Westphal and Jann method (41). 
Endotoxin was prepared by the butanol/water extraction procedure 
(29). Briefly, 0.25 g wet weight of whole cell paste was suspended in 1 
ml water with an equal volume of butanol added. The endotoxin 
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partitioned to the aqueous phase below the butanol. The butanol phase 
was extracted with half the original volume of water three times. The 
pooled aqueous phase was digested with Pronase (20 µg/ ml fmal 
concentration) in 0 .2 M Na3P04 buffer (pH 7.0) overnight at 37°C. The 
digested endotoxin preparation was centrifuged at 10,000 x g for 40 
minutes and the precipitated interphase removed. The endotoxin 
solution was exhaustively dialyzed , concentrated, lyophylized, and 
stored at -20°C until assays were performed. 
The LPS and endotoxin preparations were dissolved in pyrogen-
free saline and sterilized by heating to 100°C for 10 minutes. These 
solutions were stored at 4 °C until use. The prepartations were heated 
for 1 - 2 minutes at 100°C before use in assays. 
Macrophage viability Peritoneal exudate cells (PECs) from 
BALBI cByJ mice were harvested by peritoneal lavage 3 - 4 days after an 
interperitoneal injection of 2 mls fluid thioglycollate (Difeo, Detroit, 
MI). PECs were lavaged with phosphate buffered saline (PBS - 8 g NaCl, 
1.15 g Na2HP04, 0 .2 g KH2P04, to 1 liter H20, pH 7.2) supplemented 
with 10 units/ml heparin and 1 % fetal calf serum (FCS, JR Scientific, 
Irvine, CA). PECs were washed in RPMI supplemented with 37 mg/ml 
NaHC03, 25 units/ml penicillin, 25 µg/ml streptomycin (P / S). 2 mM L-
glutamine (L-glu). and 1 % FCS, then resuspended in the same medium 
at 5 x 106 cells/ml and aliquoted into sterile 13 x 100 mm 
polypropylene snap cap tubes. Dilutions of LPS or endotoxin were 
added to the tubes. The tubes were rotated end over end at 37°C for 24 
hours and then stained with 10 µI of PBS containing 0.5 mg/ml 
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propidium iodide (33) and/ or 100 µl of PBS containing a 1: 1000 
dilution of a 0 .5% (w/v) fluorescein diacetate-acetone stock solution. 
Using fluorescent microscopy, this procedure allows the differentiation 
of live (green) and dead (orange to red) cells. Cells were incubated for 
15 - 30 minutes at room temperature and were counted using a 
fluorscent microscope (Leitz Orthoplan, Wetzlar, Germany) or a 
fluorescence activated cell sorter (Coulter, Luton, England). 
Interleukin 1 assay Thioglycollate elicited PECs from BALBI cByJ 
mice were harvested (see above). washed, resuspended, and adjusted to 
1 x 106 cells/ml in RPMI 1640 (P/S. L-glu, NaHC03) . Cultures (1 ml) 
were stimulated for varying lengths of time with various doses of LPS or 
endotoxin and incubated at 37°C in 5% C02. At the indicated time, 
supernatant fluid was harvested by centrifugation and stored at -70°C 
until use. Dl0.G4. l cells were centrifuged through a density gradient 
(Ficoll-paque 1.077) to concentrate live cells. After washing three 
times to remove excess gradient material, cells were resuspended to 5 
x 105 cells/ml in RPMI 1640 (P /S, L-glu, 10 mM HEPES, 5% FCS) and 
0.1 ml was added to each well of a 96 well microtiter plate (Costar 
#3799, St. Louis, MO) . Cultures were incubated 72 hours and 0.5 µC of 
3H-thymidine (Arlington Heights, IL) was added during the last 8 hours. 
Samples were harvested on to filter paper discs with an automatic 
harvester (Bellco, Vineland, NJ). dried, and counted using liquid 
scintillation. 
Tumor ne crosis factor assay L929 cells were scrapped and 
resuspended to 5 x 105/ml in MEM (P/S, L-glu, NaHC03) 
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supplemented with 10% horse serum (Gibco, Irvine, CA). One tenth ml 
was added to each well of a 96 well microtiter plate (Costar #3799) and 
incubated overnight at 37°C in 5% C02. Supernatant fluid from LPS or 
endotoxin stimulated PECs was added at increasing dilutions along with 
MEM medium containing actinomycin D (final concentration of 
actinomycin Din a well was 2.5 µg/ml). Anti-TNF rabbit serum 
(Genzyme, Orvala, FL) was added to additional wells to inhibit TNF 
activity present in the supernatant. This assay was terminated after 18 
hours by washing plates with PBS to remove nonadherent cells. 
Residual monolayers were stained with a 0.2% crystal violet - 2% 
formalin solution for 20 minutes (10) . Plates were washed in water 3 
times, with the third wash standing 10 minutes. The stain was then 
solublized in 50% ethanol and quantitated by measuring the adsorbance 
at 595 nm on an ELISA reader (Biotek Instruments model EL 301, 
Winooski, Vf) (34). Quadruplica te wells were set up with results 
expressed as the percent cytotoxicity + S.E.M. 
Natural killer cell assay C3H/HeN mice were injected i.p. 24 
hours prior to the assay with LPS or endotoxin. Mice were sacrificed by 
cervical dislocation and individual spleens were removed and minced 
into single cell suspensions. Red blood cells were removed by 
hypotonic shock induced by resuspending each spleen in 2 ml of RPMI 
1640 (1% FCS, P/S, L-glu, HEPES) to which 6 ml of sterile distilled 
water was added. After 30 seconds, 2 mls of 3 .5% saline was added. 
Cells were then washed three times in the same medium to remove red 
blood cell debris. Cells were then resuspended to 5 xl06 cells/ml in 
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NK medium (RPMI 1640 supplemented with P/S, L-glu, HEPES, 10% 
FCS, 5 x 1 o-4 M 2-mercaptoethanol) and 0 . 1 ml added to each well of a 
96 well U-bottom microtiter plate (Falcon #3910, Oxnard, CA). YAC-1 
cells (1.2 x 107) were labeled with 200 µCi of 51Cr in NK medium 
supplemented with 0 .25% sucrose for 90 minutes. Cells were washed 
in NK medium three times. 
Spleen cells were resuspended to 2 x 105 /ml and 0 .1 ml was 
added to each well of a 96 well U-bottom microtiter plate. 51Cr labeled 
YAC-1 cells were then added to each well at ratios of effector cell 
(spleen) to target cell (YAC-1) of 100: 1, 50: 1, or 25: 1. Plates were 
incubated four hours at 37°C in 5% C02. Harvesting of the supernatant 
was carried out using harvesting frames (Skatron #7072, Sterling, VA) 
with a plastic tube (USA Scientific Plastics #USA8845, Ocala, FL). 
Samples were immediately counted in a gamma counter (Beckman 
Biogamma II, Beckman Instruments, Inc ., Fullerton, CA) The results 
were expressed as 
% cytotoxicity = experimental CPM - spontaneous CPM x 100 
total CPM - spontaneous CPM 
Suppression assay BALB/cByJ mice were injected with endotoxin 
or LPS i.p. 24 hours prior to an injection of 10% sheep red blood cell 
suspension (SRBC). Four days after the injection of the SRBCs, mice 
were sacrificed by cervical dislocation, spleens were removed, minced, 
washed in Hank's balanced salt solution, and resuspended in the same 
solution. The anti-SRBC plaque forming cell (PFC) response was 
determined using the Cunningham slide method (20). 
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RESULTS 
Macrophage viability The effect of LPS and endotoxin on 
macrophage viability was assayed by fluorescent microscopy using 
propidium iodide and fluorescein diacetate. The results depicted in 
Table 1 show that the treponemal LPS preparations were toxic to 
elicited PECs at 100 µg/million cells while the endotoxin preparations 
were not toxic. In comparison to E. coli LPS, the treponemal LPS 
preparations were less toxic for murine PECs. 
IL-1 production Both time and dose dependent assays were 
performed to determine the optimum conditions for IL 1 production. 
The data in Figure 1 shows that treponemal endotoxins were able to 
induce the secretion of IL 1 while the LPS preparations failed to 
stimulate IL 1 production. The optimal responses were observed at 
doses greater than 0.5 µg/ml (Fig. 2). The treponemal endotoxins 
induced responses much better than their corresponsing LPS 
preparations (Fig. 1 and Fig. 2) . The endotoxins (5 µg/ml) elicited 
responses similiar to those obtained with E. coli LPS (0.1 µg/ml) . 
Production of TNF There was no difference in the levels of TNF 
activity in culture supernatants from PEC stimulated with treponemal 
endotoxin preparations (Fig. 4). At the lower dilutions of PEC 
supematants (1:5 and 1:25). the T. innocens LPS induced better TNF 
activity ~ 65% cytotoxicity) than T. hyodysenteriae LPS Gs. 45% cyto-
toxicity). The levels of TNF induced by 5 µg/ml of the treponemal 
endotoxins were similiar to those induced by 0.1 µg/ml of E. coli LPS. 
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The presence of TNF in the supernatants from PECs stimulated with E. 
coli LPS and T. hyodysenteriae endotoxin was confirmed by the ability 
to inhibit the cytotoxic activity with rabbit anti-TNF antisera (Fig. 5). 
Tablel. Effect of treponemal LPS or endotoxin on BALBI cByJ 
peritoneal exudate cell viability 
Preparation amount added Viability (%) of PEca 
(µg) Elicitedb Residentc 
None 67.7 70.9 
E. coli K235 
LPS 25 24.5 56.4 
100 15.2 53.8 
T. hyodysenteriae 
B204 
LPS 25 63.1 78.0 
100 38.5 74.3 
endotoxin 25 73.2 78.0 
100 66.4 80.3 
T. innocens Bl555a 
LPS 25 60.l 72.l 
100 45.4 56.5 
endotoxin 25 76.1 83.3 
100 78.6 88.l 
aproteose peptone elicited or resident BALB/cByJ PECs, 1 x 106 
cells/ml, were incubated for 24 hours in the presence or absence of 
LPS or endotoxin. 
bViability of elicited PECs was determined using a fluorescent 
activated cell sorter. For each sample, 10,000 cells were counted. 
cviability of resident PECs was determined by ultraviolet 
microscopy and 300 cells or 10 microscopic fields (250x) were 
enumerated per sample. 
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The TNF activity of all PEC supematants could be inhibited with the 
addition of the anti-TNF rabbit serum (data not shown). 
Natural killer cell assay Augmentation of natural killer (NK) cell 
activity can be achieved by treating mice i.p. with LPS and endotoxin. 
This augmentation is the result of the elaboration of interferon. 
Therefore, as a crude measure of in vivo interferon production, the 
ability of treponemal LPS or endotoxin to enhance NK cell activity was 
determined (Fig. 6). The NK activity in mice treated with T. innocens 
or T. hyodysenteriae endotoxin was significantly higher than control 
response (p ~ 0.05). The T. hyodysenteriae LPS preparation augmented 
NK activity above the saline control (p ~ 0.1) but the T. innocens LPS 
preparation did not augment the NK response above control levels. 
Suppression assay In addition to the ability of LPS to enhance an 
immune response, it has been shown to inhibit the antibody response 
to antigens administered subsequent to LPS injection. The suppression 
of an anti-SRBC PFC response by LPS or endotoxin was assayed using 
C3H/HeN mice. Mice were given an i.p. injection of LPS or endotoxin 
24 hours before immunization with SRBC. At doses of 10 and 100 
µg/mouse, the T. hyodysenteriae endotoxin inhibited the subsequent 
anti-SRBC PFC response by 54% (Fig. 7). At 100 µg/mouse, the T. 
hyodysenteriae LPS suppressed the PFC response by only 38% while 1 O 
µg/mouse of E. coli LPS suppressed the response by 65%. 
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FIG. 1. A time dependent IL 1 response was determined for PEC 
cultures treated with treponemal LPS or endotoxin. The ILl-
dependent DlO.G.4 T cell clone was used to measure IL 1 
activity. The supernatants (1:20 dilution) were prepared using 
0.1 µg/ml E. coli LPS (square). 5 µg/ml LPS (circle), and 5 
µg/ml endotoxin (triangle). and RPMI control (X). A.) T. 
hyodysenteriae B204; B.) T. innocens Bl555a. Values 
represent the mean CPM + S.E.M. of triplicate cultures. 
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FIG. 2 . A dose dependent response for the production of ILl was 
determined for PECs stimulated with treponemal LPS or 
endotoxin. Supematants were diluted 1: 10. T. hyod.ysenteriae 
B204 LPS (open square): B204 endotoxin (shaded square): T. 
innocens B l 555a LPS (open triangle): and Bl555a endotoxin 
(shaded triangle). Supernatants from PECs stimulated with 0 .1 
µg/ml E. coli LPS induced 110,000 CPM. Values are expressed 
as the mean + S.E.M. of triplicate cultures. 
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FIG. 3. Tumor necrosis factor activity was assayed by adding diluted 
culture supernatant from murine peritoneal exudate cells, 
stimulated with LPS or endotoxin, to L929 cells. After 20 - 24 
hours, plates were washed and then stained with crystal violet 
to visualize adherent cells. Absorbance of the samples were 
read at 595 nm. Each value represents the mean + S.E.M. of 
quadruplicate cultures and divided by the average of control 
cultures and multiplied by 100. A.) E. coli LPS, 0.1 µg/ml 
(open bar): T. hyodysenteriae B204 LPS, 5 µg/ml (slashed 
bar); B204 endotoxin, 5 µg/ml (shaded bar); B.) E. coli LPS, 
0.1 µg/ml (open bar); T. innocens Bl555a LPS, 5 µg/ml 
(slashed bar); and Bl555a endotoxin, 5 µg/ml (shaded bar). 
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FIG. 4. Tumor necrosis factor activity was suppressed by the addition of 
r abbit anti-TNF serum (2 units/well). Thioglycollate elicited 
BALB/cByJ PECs were stimulated with T. hyodysenteriae B204 
endotoxin (0.5 µg/ml) and E. coli LPS (0.1 µg/ml) and 
supematants were collected at 48 hours. The supematants 
were diluted 1 :75 and treated with 2 units/well anti-TNF and 
compared to untreated supernatant. Results are expressed as 
mean + S .E.M. of duplicate cultures. 
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FIG. 5. Natural killer cell activity was assayed by a 51Cr release assay 
using YAC-1 cells as the target and spleen cells from C3H/HeN 
mice as effector cells. The ratio of effector cells to target cells 
was 50: 1. Mice were given i.p. injections of LPS or endotoxin 
24 hours prior to assay. Treponemal preparations were given at 
100 µg/mouse, poly IC at 100 µg/mouse, and E.coli LPS at 
20µg/mouse. This assay was carried out in triplicate and values 
are expressed as the mean ± S.E.M. 
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FIG. 6. Studies on the suppressive effect of LPS and endotoxin on the 
anti-SRBC PFC response. LPS was given to BALB/cByJ mice 24 
hours prior to the SRBC immunization. On day 4, anti-SRBC 
PFCs were determined. Each group contained five animals and 
values are expressed as the mean + S.E.M. per million 
splenocytes. 
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DISCUSSION 
Swine dysentery is an inflammatory disease of the porcine cecum 
and large intestine (12) . Symptoms of the disease include fever, 
anorexia, and yellow to gray soft feces. Diarrheic stools often contain 
fibrin, mucus, and blood flecks as the disease progresses. Gross lesions 
are characterized as necrotic, catarrhal, and hemorrhagic (12) . 
The specific component(s) of T. hyodysenteriae that induce the 
inflammatory condition have not been defined. The initial event in 
many infections is the development of an inflammatory response, and 
bacterial LPS or endotoxin has been shown to contribute to these 
inflammatory conditions (27). Habicht et al. (11) and Beck et al. (2) 
reported that macrophages produced IL 1 following stimulation with 
whole cells of Borrelia burgdorjeri. In addition, it was shown that these 
IL 1 preparations could provide both the preparatory or provocative 
stimuli for a local Shwartzman reaction. As discussed in Section I, the 
treponemal preparations failed to induce a dermal Shwartzman reaction 
in rabbits, but were capable of providing the provocative stimulus 
following an intradermal injection of E. coli LPS. The inability of 
treponemal LPS or endotoxin to induce necrotic lesions indicated that 
these preparations were not inflammatory agents. This would be 
inconsistent with the results obtained with other LPS preparations (27) 
and may be explained by the inability of the treponemal preparations to 
induce endogenous pyrogens (i.e., IL 1 or TNF) . 
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Macrophages have been shown to secrete both IL 1 and TNF 
following stimulation with LPS or endotoxin (7a, 8, 27). Interleukin 1 
is a 15,000 dalton protein with hormone action (7a, 9). The effects of 
IL 1 on the immune system include enhanced expression of cell surface 
markers, enhanced antibody production, and stimulated T cell 
proliferation (7a, 9). Tumor necrosis factor is also a protein and has a 
molecular weight of 17,000 daltons (3). When macrophages are 
stimulated with LPS, TNF can account for as much as 1-2% of the total 
protein produced (3). Tumor necrosis factor has been shown to be the 
mediator of toxic shock following administration of endotoxin (37). 
Like IL 1, TNF induced the biosynthesis of various inflammatory agents 
including prostaglandins, leukotrienes, platelet activating factor, and 
collagenase (8). Depending on the magnitude of the response to an 
infectious agent, these monokines can have beneficial or deleterious 
effects on the host. The contribution of these monokines to the 
pathogenesis of swine dysentery is not known. However, the 
inflammation and edema observed in dysenteric lesions would be 
consistent with the synthesis and secretion of IL 1 and TNF. 
Murine PECs stimulated with the treponemal endotoxins produced 
a dose-dependent response (Fig. 2). Though comparable IL 1 responses 
were elicited by E. coli LPS and the treponemal endotoxins, the dose of 
endotoxin was 50 fold higher than that of E. coli LPS. The treponemal 
LPS preparations did not stimulate IL 1 release (Fig. 1 and 2). Beck et. 
al. (2) demonstrated that IL 1 can provide the preparatory and 
provocative stimuli for a Schwartzman reaction. The lack of IL 1 
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secretion from PECs treated with treponemal LPS may explain the 
inability of these preparations to induce a local Shwartzman reaction 
(Section I). 
The TNF activity, like IL 1 production, was stimulated by 
treponemal endotox.ins, but not the LPS preparations (Fig. 4). The 
presence of TNF in the culture supernatants was demonstrated by the 
addition of rabbit anti-TNF serum (Fig. 4). As observed for IL 1 
production, the level of TNF in PEC culture supernatant following 
stimulation with endotoxin was similar to that obtained withE. coli LPS, 
but the dose required was 50 fold higher. 
The endotoxin protein of P. aeruginosa has been shown to induce 
interferon both in vitro and in vivo at greater levels than LPS (18). The 
ability of the treponemal preparations to induce both IL 1 and TNF 
seem to coincide with the presence of protein in the endotox.in 
preparations. Therefore, the NK cell tumoricidal assay was used to 
indirectly measure in vivo interferon production following stimulation 
with treponemal LPS or endotoxin (7b). The NK activity was 
augmented by both endotoxin preparations (p $; 0.05). but little activity 
was seen from the treponemal LPS preparations (Fig. 5). 
The treponemal endotoxins were observed to have very little effect 
on murine PEC viability (Table 1). For resident PECs, T. innocens LPS 
was toxic at 100 µg/ml, but not at 25 µg/ml. At 100 µg/ml, T. 
hyodysenteriae and T. innocens LPS were toxic for elicited PECs. It has 
been previously shown that the lipid component of LPS is responsible 
for the associated toxicity (26). On a weight basis, the increased 
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toxicity of the treponemal LPS in comparison to the endotoxin 
preparations may be related to the increased amount of the lipid 
component. Results of this study differ with the previous report by 
Nuessen et al. (28) in that the treponemal LPS was shown to be toxic at 
15 µg/ ml and higher rather than 100 µg/ ml. This difference may be 
explained by the use of different preparations and/ or the method used 
to determine macrophage viability. For example, the determination of 
macrophage viability based on the number of adherent cells remaining 
after treatment with LPS may have been incorrectly interpreted. It was 
recently shown that LPS will cause macrophages to release from glass 
surfaces without affecting viability (16). This may have led the previous 
authors (28) to report toxic effects at lower doses of LPS than observed 
in the present study. In addition, the toxicity of the treponemal LPS 
relative to E. coli LPS cannot be compared since the previous authors 
(28) did make that comparison. 
Previous reports have established that endotoxin (butanol/water 
extraction) preparations contain LAP (23) as well as outer membrane 
porins (36). The addition of protein components change the LPS 
molecule, thus changing what is seen by the host system (13). The 
biologic differences between endotoxin and LPS could be accounted for 
by the addition of these protein moieties. These proteins may work 
alone to give the responses seen in this study. 
In addition to the effects on macrophages, LPS has been shown to 
suppress the immune response to a T cell-dependent antigen (38). 
This suppression was observed when the LPS was given 24 to 48 hours 
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prior to antigen presentation. Treatment of mice with the treponemal 
preparations resulted in significant reduction (p $ 0.05) of the anti-
SRBC PFC response (Fig. 6). 
We have shown that the treponemal LPS is biologically less active 
on the immune response than treponemal endotoxin or E. coli LPS. 
The results of the present study coincide with the results of the 
previous study (Section I). The contribution of treponemal LPS or 
endotoxin to the development of dysenteric lesions is unknown. These 
lesions may be the result of the host's own inflammatory response or 
the direct action of the spirochete. It has been shown that the 
treponemal endotoxin stimulated inflammatory agents (i.e., IL 1 and 
TNF) although at lesser amounts than that induced by classical LPS. 
This apparent difference in the ability to induce inflammatory agents 
may have little bearing on the development of lesions since the absolute 
amount of IL 1 or TNF required is not known. 
The LPS preparations of T. hyodysenteriae and T. innocens were 
shown to be less toxic for murine PECs than E. coli LPS and did not 
induce monokine production. The endotoxin preparations stimulated 
PECs to produce IL 1 and TNF. Although activity was comparable to E. 
coli LPS, the doses of treponemal endotoxin required for these 
responses were 50 fold higher. In addition, the biologic activity of the 
treponemal preparations was dependent on the presence of the protein 
component. Finally, the results suggest that the differences in 
virulence between T. hyodysenteriae and T. innocens is not based on 
the biologic activity of their LPS or endotoxin components. 
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GENERAL CONCLUSION 
Lipopolysaccharide (LPS) and endotoxin from Treponema 
hyodysenteriae and T. innocens were studied to determine the biologic 
activity, primarily using the murine model system. 
Ch emical composition varied slightly between the different 
preparations. T. hyodysenteriae LPS had similar hexose content but 
relatively little protein content compared to the treponemal LPS in 
previous reports. The classic LPS biologic responses (pyrogenicity, 
mitogenicity, adjuvanticity, lethality, Limulus assay, and dermal 
Shwartzman reaction) of treponemal preparations were relatively weak 
compared to Escherichia coli LPS. with the exception of the Limulus 
assay giving comparable activities to both. 
Stimulation of lymphoreticular cells by Treponema preparations 
was weak. It was observed that treponemal preparations were, when 
compared to E. coli LPS, less toxic to macrophage, weakly stimulatory 
for interleukin 1 and tumor n ecrosis factor production, weakly 
a ugm ented natural killer cell activity, and showed mild suppressive 
effects on the murine immune system. 
The results of this study indicate that there is little difference in 
the biologic activities of T. hyodysenteriae and T. innocens LPS and 
endotoxin. Virulence of the two organisms is not dependent on 
biologic activity of the LPS and the biologic activity of the endotoxin 
preparations coincided with the presence of protein. 
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